References
Chambers CD, Johnson BA, Dick LM, Felix RJ, Jones KL (1996) Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335: 1010–1015
Costei AM, Kozer E, Ho T, Ito S, Koren G (2002) Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 156: 1129–1132
Dahl ML, Olhager E, Ahlner J (1997) Paroxetine withdrawal syndrome in a neonate (letter). Br J Psychiatry 171: 391–392
Gerola O, Fiocchi S, Rondini G (1999) Antidepressant therapy in pregnancy: a review from the literature and report of a suspected paroxetine withdrawal syndrome in a newborn. Rivista Italiana di Pediatria 25: 216–218
Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Moller HJ (1998) The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci 248: 96–103
Isbister GK, Dawson A, Whyte IM, Prior FH, Clancy C, Smith AJ (2001) Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? Arch Dis Child Fetal Neonatal Ed 85: F147–F148
Kaye CM, Haddock RE, Langley PF, Mellows G, Tasker TC, Zussman BD et al (1989) A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand Suppl 350: 60–75
Martensson B, Wagner A, Beck O, Brodin K, Montero D, Asberg M (1991) Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder. Acta Psychiatr Scand 83: 125–133
Mhanna MJ, Bennet JB, Izatt SD (1997) Potential fluoxetine chloride (Prozac) toxicity in a newborn (letter). Pediatrics 100: 158–159
Nisijima K (2000) Abnormal monoamine metabolism in cerebrospinal fluid in a case of serotonin syndrome (letter). J Clin Psychopharmacol 20: 107–108
Price JS, Waller PC, Wood SM, MacKay AV (1996) A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol 42: 757–763
Spencer MJ (1993) Fluoxetine hydrochloride (Prozac) toxicity in a neonate. Pediatrics 92: 721–722
Stiskal JA, Kulin N, Koren G, Ho T, Ito S (2001) Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed 84: F134–F135
Acknowledgements
We thank the Institute of Neurology, London for doing the analysis on CSF and the Department of Toxicology, Royal Hallamshire Hospital, Sheffield, for assaying olanzapine and paroxetine concentrations in plasma.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jaiswal, S., Coombs, R.C. & Isbister, G.K. Paroxetine withdrawal in a neonate with historical and laboratory confirmation. Eur J Pediatr 162, 723–724 (2003). https://doi.org/10.1007/s00431-003-1293-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-003-1293-9